Yabao Pharma In-licenses China Rights to Parkinson's Drug Technology

Yabao Pharmaceutical in-licensed greater China rights to a Parkinson's disease kinase target from MRC Technology of the UK. MRC Tech describes itself as a charity that operates as a technology transfer unit for the UK's Medical Research Council. After identifying projects with further potential, MRC Tech offers IP management and R&D. MRC Tech will retain rights to the target outside of China, Taiwan and Hong Kong. More details.... Stock Symbol: (SHA: 600351) Share this with colleagues: // //